Type II diabetes abrogates sex differences in endothelial function in premenopausal women

Circulation

Volumn 101, Issue 17, 2000, Pages 2040-2046

  Steinberg, Helmut O ^a   Paradisi, Giancarlo ^a   Cronin, Jessica ^a   Crowde, Kristin ^a   Hempfling, Annette ^a   Hook, Ginger ^a,b   Baron, Alain D ^a,b  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Richard L Roudeboush Vet Aff M   (United States)

Author keywords

Diabetes mellitus; Endothelium; Obesity; Sex

Indexed keywords

METHACHOLINE CHLORIDE; N(G) METHYLARGININE; NITRIC OXIDE SYNTHASE INHIBITOR; NITROPRUSSIDE SODIUM; VASODILATOR AGENT;

ADULT; ARTICLE; CARDIOVASCULAR RISK; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; FEMALE; HUMAN; INCIDENCE; LEAN BODY WEIGHT; LEG BLOOD FLOW; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PREMENOPAUSE; PRIORITY JOURNAL; SEX DIFFERENCE; VASCULAR DISEASE; VASCULAR ENDOTHELIUM;

EID: 0034595287     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.101.17.2040     Document Type: Article

References (36)

1. Jousilahti P, Tuomilehto J, Vartiainen E, Pekkanen J, Puska P. Body weight, cardiovascular risk factors, and coronary mortality: 15-year follow-up of middle-aged men and women in eastern Finland. Circulation. 1996;93:1372-1379.
2. Seidell JC, Verschuren WM, van Leer EM, Kromhout D. Overweight, underweight, and mortality: a prospective study of 48,287 men and women. Arch Intern Med. 1996;156:958-963.
3. From the Centers for Disease Control and Prevention. Update: prevalence of overweight among children, adolescents, and adults - United States, 1988-1994. JAMA. 1997;277:1111.
4. Reaven GM. Syndrome X: 6 years later. J Intern Med. 1994;236:13-22.
5. Steinberg HO, Chaker H, Learning R, Johnson A, Brechtel G, Baron AD. Obesity/insulin resistance is associated with endothelial dysfunction: implications for the syndrome of insulin resistance. J Clin Invest. 1996; 97:2601-2610.
6. Lloyd-Jones DM, Bloch KD. The vascular biology of nitric oxide and its role in atherogenesis. Annu Rev Med. 1996;47:365-375.
7. Pan WH, Cedres LB, Liu K, Dyer A, Schoenberger JA, Shekelle RB, Stamler R, Smith D, Collette P, Stamler J. Relationship of clinical diabetes and asymptomatic hyperglycemia to risk of coronary heart disease mortality in men and women. Am J Epidemiol. 1986;123: 504-516.
8. Kannel WB, McGee DL. Diabetes and cardiovascular disease: the Framingham study. JAMA. 1979;241:2035-2038.
9. Hubert HB, Feinleib M, McNamara PM, Castelli WP. Obesity as an independent risk factor for cardiovascular disease: a 26 year follow up of participants in the Framingham Heart Study. Circulation. 1983;67: 968-977.
10. Manson JE, Willett WC, Stampfer MJ, Colditz GA, Hunter DJ, Hankinson SE, Hennekens CH, Speizer F. Body weight and mortality among women. N Engl J Med. 1995;333:677-685.
11. Kannel WB, Hjortland MC, McNamara PM, Gordon T. Menopause and risk of cardiovascular disease: the Framingham study. Ann Intern Med. 1976;85:447-452.
12. Jarrett RJ, McCartney P, Keen H. The Bedford survey: ten year mortality rates in newly diagnosed diabetics, borderline diabetics and normoglycaemic controls and risk indices for coronary heart disease in borderline diabetics. Diabetologia. 1982;22:79-84.
13. Pyorala K, Laakso M, Uusitupa M. Diabetes and atherosclerosis: an epidemiologic view. Diabetes Metab Rev. 1987;3:463-524.
14. Urakami-Harasawa L, Shimokawa H, Nakashima M, Egashira K, Takeshita A. Importance of endothelium-derived hyperpolarizing factor in human arteries. J Clin Invest. 1997;100:2793-2799.
15. McCulloch Al, Randall MD. Sex differences in the relative contributions of nitric oxide and EDHF to agonist-stimulated endothelium-dependent relaxations in the rat isolated mesenteric arterial bed. Br J Pharmacol. 1998;123:1700-1706.
16. Forte P, Kneale BJ, Milne E, Chowienczyk PJ, Johnston A, Benjamin N, Ritter JM. Evidence for a difference in nitric oxide biosynthesis between healthy women and men. Hypertension. 1998;32:730-734.
17. Gerhard M, Roddy MA, Creager SJ, Creager MA. Aging progressively impairs endothelium-dependent vasodilation in forearm resistance vessels of humans. Hypertension. 1996;27:849-853.
18. Panza JA, Quyyumi A, Brush JE, Epstein SE. Abnormal endothelium dependent vascular relaxation in patients with essential hypertension. N Engl J Med. 1990;323:22-27.
19. Steinberg HO, Tarshoby M, Monestel R, Hook G, Cronin J, Johnson A, Bayazeed B, Baron AD. Elevated circulating free fatty acid levels impair endothelium-dependent vasodilation. J Clin Invest. 1997;100:1230-1239.
20. Casino PR, Kilcoyne CM, Quyyumi AA, Hoeg JM, Panza JA. The role of nitric oxide in endothelium-dependent vasodilation of hypercholesterolemic patients. Circulation. 1993;88:2541-2547.
21. Deurenberg P, Weststrate JA, Seidell JC. Body mass index as a measure of body fatness: age- and sex-specific prediction formulas. Br J Nutr. 1991;65:105-114.
22. Nuutila P, Knuuti MJ, Maki M, Laine H, Ruotsalainen U, Teras M, Haaparanta M, Solin O, Yki-Jarvinen H. Gender and insulin sensitivity in the heart and in skeletal muscles: studies using positron emission tomography. Diabetes. 1995;44:31-36.
23. Yki-Jarvinen H. Sex and insulin sensitivity. Metabolism. 1984;33: 1011-1015.
24. Petrie JR, Ueda S, Webb DJ, Elliott HL, Connell JMC. Endothelial nitric oxide production and insulin sensitivity: a physiological link with implications for pathogenesis of cardiovascular disease. Circulation. 1996;93:1331-1333.
25. Lantin-Hermoso RL, Rosenfeld CR, Yuhanna IS, German Z, Chen Z, Shaul PW. Estrogen acutely stimulates nitric oxide synthase activity in fetal pulmonary artery endothelium. Am J Physiol. 1997;273: L119-L126.
26. Kauser K, Rubanyi GM. Gender difference in bioassayable endothelium-derived nitric oxide from isolated rat aortae. Am J Physiol. 1994;267:H2311-H2317.
27. Huang A, Sun D, Koller A, Kaley G. Gender difference in flow-induced dilation and regulation of shear stress: role of estrogen and nitric oxide. Am J Physiol. 1998;275:R1571-R1577.
28. Pinto S, Virdis A, Ghiadoni L, Bernini G, Lombardo M, Petraglia F, Genazzani AR, Taddei S, Salvetti A. Endogenous estrogen and acetylcholine-induced vasodilation in normotensive women. Hypertension. 1997;29:268-273.
29. Tagawa H, Shimokawa H, Tagawa T, Kuroiwa-Matsumoto M, Hirooka Y, Takeshita A. Short-term estrogen augments both nitric oxide-mediated and non-nitric oxide-mediated endothelium-dependent forearm vasodilation in postmenopausal women. J Cardiovasc Pharmacol. 1997;30: 481-488.
30. Herman SM, Robinson JTC, McCredie RJ, Adams MR, Boyer MJ. Androgen deprivation is associated with enhanced endothelium dependent-vasodilation in adult men. Arterioscler Thromb Vasc Biol. 1997;17:2004-2009.
31. Herranz L, Zapata A, Grande C, Megia A, Pallardo LF. Body fat distribution, insulin mediated suppression of non-esterified fatty acids and plasma triglycerides in obese subjects. Harm Metab Res. 1998;30:141-145.
32. Boden G. Free fatty acids (FFA), a link between obesity and insulin resistance. Front Biosci. 1998;3:D169-D175.
33. Gupta MP, Steinberg H, Baron A, Hart CM. Fatty acids impair nitric oxide production in cultured endothelial cells. J Invest Med. 1998; 46:288A. Abstract.
34. Davda RK, Stepniakowski KT, Lu G, Ullian ME, Goodfriend TL, Egan BM. Oleic acid inhibits endothelial nitric oxide synthase by a protein kinase C-independent mechanism. Hypertension. 1995;26:764-770.
35. Cannon RO III. Role of nitric oxide in cardiovascular disease: focus on the endothelium. Clin Chem. 1998;44:1809-1819.
36. UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet. 1998;352:837-853.